Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 545 | 195 | 1,024 | 25,554 | 24,590 |
| Gross Profit | 545 | 195 | 1,024 | 25,554 | 24,590 |
| Operating Expenses | 73,583 | 48,839 | 46,308 | 63,911 | 60,783 |
| Operating Income | -73,038 | -48,644 | -45,284 | -38,357 | -36,193 |
| Interest Expense | 1,004 | 1,361 | 1,403 | 1,242 | 891 |
| Other Income | 2,431 | 1,063 | 458 | 87 | 319 |
| Pre-tax Income | -71,611 | -48,942 | -46,229 | -39,512 | -36,765 |
| Net Income Continuous | -71,611 | -48,942 | -46,229 | -39,512 | -36,472 |
| Net Income Discontinuous | N/A | -3,547 | -3,958 | -5,466 | N/A |
| Net Income | $-71,611 | $-52,489 | $-50,187 | $-44,978 | $-36,472 |
| EPS Basic Total Ops | -1.73 | -1.70 | -2.37 | -6.24 | -6.78 |
| EPS Basic Continuous Ops | -1.73 | -1.59 | -2.19 | -5.48 | -6.77 |
| EPS Basic Discontinuous Ops | N/A | -0.11 | -0.18 | -0.76 | N/A |
| EPS Diluted Total Ops | -1.73 | -1.70 | -2.37 | -6.24 | -6.78 |
| EPS Diluted Continuous Ops | -1.73 | -1.59 | -2.19 | -5.48 | -6.77 |
| EPS Diluted Discontinuous Ops | N/A | -0.11 | -0.18 | -0.76 | N/A |
| EBITDA(a) | $-70,370 | $-44,527 | $-39,755 | $-32,110 | $-31,123 |